These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 19357294)
1. Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes. Fan X; Ding Y; Brown S; Zhou L; Shaw M; Vella MC; Cheng H; McNay EC; Sherwin RS; McCrimmon RJ Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1702-8. PubMed ID: 19357294 [TBL] [Abstract][Full Text] [Related]
2. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. McCrimmon RJ; Fan X; Ding Y; Zhu W; Jacob RJ; Sherwin RS Diabetes; 2004 Aug; 53(8):1953-8. PubMed ID: 15277372 [TBL] [Abstract][Full Text] [Related]
3. AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat. McCrimmon RJ; Evans ML; Jacob RJ; Fan X; Zhu Y; Shulman GI; Sherwin RS Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1076-83. PubMed ID: 12376337 [TBL] [Abstract][Full Text] [Related]
4. Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. McCrimmon RJ; Fan X; Cheng H; McNay E; Chan O; Shaw M; Ding Y; Zhu W; Sherwin RS Diabetes; 2006 Jun; 55(6):1755-60. PubMed ID: 16731839 [TBL] [Abstract][Full Text] [Related]
5. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia. McCrimmon RJ; Shaw M; Fan X; Cheng H; Ding Y; Vella MC; Zhou L; McNay EC; Sherwin RS Diabetes; 2008 Feb; 57(2):444-50. PubMed ID: 17977955 [TBL] [Abstract][Full Text] [Related]
6. Insulin regulates GLUT4 in the ventromedial hypothalamus to restore the sympathoadrenal response to hypoglycemia in diabetic rats. Agrawal R; Vieira-de-Abreu A; Durupt G; Taylor C; Chan O; Fisher SJ Am J Physiol Endocrinol Metab; 2018 Dec; 315(6):E1286-E1295. PubMed ID: 30226996 [TBL] [Abstract][Full Text] [Related]
7. Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Borg MA; Borg WP; Tamborlane WV; Brines ML; Shulman GI; Sherwin RS Diabetes; 1999 Mar; 48(3):584-7. PubMed ID: 10078560 [TBL] [Abstract][Full Text] [Related]
12. Modulation of β-adrenergic receptors in the ventromedial hypothalamus influences counterregulatory responses to hypoglycemia. Szepietowska B; Zhu W; Chan O; Horblitt A; Dziura J; Sherwin RS Diabetes; 2011 Dec; 60(12):3154-8. PubMed ID: 22013013 [TBL] [Abstract][Full Text] [Related]
13. Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemia. Zhu W; Czyzyk D; Paranjape SA; Zhou L; Horblitt A; Szabó G; Seashore MR; Sherwin RS; Chan O Am J Physiol Endocrinol Metab; 2010 May; 298(5):E971-7. PubMed ID: 20304763 [TBL] [Abstract][Full Text] [Related]
14. Blockade of GABA(A) receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamo-pituitary-adrenal response to hypoglycemia. Chan O; Zhu W; Ding Y; McCrimmon RJ; Sherwin RS Diabetes; 2006 Apr; 55(4):1080-7. PubMed ID: 16567532 [TBL] [Abstract][Full Text] [Related]
15. EphA5-EphrinA5 interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local glutamine/glutamate balance during hypoglycemia. Szepietowska B; Zhu W; Czyzyk J; Eid T; Sherwin RS Diabetes; 2013 Apr; 62(4):1282-8. PubMed ID: 23274893 [TBL] [Abstract][Full Text] [Related]
16. Reduction in SGLT1 mRNA Expression in the Ventromedial Hypothalamus Improves the Counterregulatory Responses to Hypoglycemia in Recurrently Hypoglycemic and Diabetic Rats. Fan X; Chan O; Ding Y; Zhu W; Mastaitis J; Sherwin R Diabetes; 2015 Oct; 64(10):3564-72. PubMed ID: 26130763 [TBL] [Abstract][Full Text] [Related]
17. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats. Oki K; Arias EB; Kanzaki M; Cartee GD Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344 [TBL] [Abstract][Full Text] [Related]
18. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion. Bradley EA; Eringa EC; Stehouwer CD; Korstjens I; van Nieuw Amerongen GP; Musters R; Sipkema P; Clark MG; Rattigan S Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1137-42. PubMed ID: 20224051 [TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase and nitric oxide regulate the glucose sensitivity of ventromedial hypothalamic glucose-inhibited neurons. Murphy BA; Fakira KA; Song Z; Beuve A; Routh VH Am J Physiol Cell Physiol; 2009 Sep; 297(3):C750-8. PubMed ID: 19570894 [TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with the AMP-kinase activator AICAR increases glycogen storage and fatty acid oxidation in skeletal muscles but does not reduce hyperglucagonemia and hyperglycemia in insulin deficient rats. Vitzel KF; Bikopoulos G; Hung S; Pistor KE; Patterson JD; Curi R; Ceddia RB PLoS One; 2013; 8(4):e62190. PubMed ID: 23620811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]